» Articles » PMID: 27226900

Endocytosis and Serpentine Filopodia Drive Blebbishield-mediated Resurrection of Apoptotic Cancer Stem Cells

Overview
Date 2016 May 27
PMID 27226900
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The blebbishield emergency program helps to resurrect apoptotic cancer stem cells (CSCs) themselves. Understanding the mechanisms behind this program is essential to block resurrection of CSCs during cancer therapy. Here we demonstrate that endocytosis drives serpentine filopodia to construct blebbishields from apoptotic bodies and that a VEGF-VEGFR2-endocytosis-p70S6K axis governs subsequent transformation. Disengagement of RalGDS from E-cadherin initiates endocytosis of RalGDS and its novel interaction partners cdc42, VEGFR2, cleaved β-catenin, and PKC-ζ as well as its known interaction partner K-Ras. We also report novel interactions of p45S6K (cleaved p70S6K) and PKM-ζ with PAK-1 filopodia-forming machinery specifically in blebbishields. Thus, a RalGDS-endocytosis-filopodia-VEGFR2-K-Ras-p70S6K axis drives the blebbishield emergency program, and therapeutic targeting of this axis might prevent resurrection of CSCs during cancer therapy.

Citing Articles

C19MC drives nucleolar invasion of mitochondria and meiotic nuclear division in human cancers.

Jinesh G, Smallin M, Mtchedlidze N, Napoli M, Lockhart J, Flores E iScience. 2024; 27(11):111132.

PMID: 39563898 PMC: 11575172. DOI: 10.1016/j.isci.2024.111132.


Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting Strategies.

Mirzayans R Curr Issues Mol Biol. 2024; 46(6):5379-5396.

PMID: 38920994 PMC: 11202608. DOI: 10.3390/cimb46060322.


Beyond Death: Unmasking the Intricacies of Apoptosis Escape.

Ergun S, Aslan S, Demir D, Kayaoglu S, Saydam M, Keles Y Mol Diagn Ther. 2024; 28(4):403-423.

PMID: 38890247 PMC: 11211167. DOI: 10.1007/s40291-024-00718-w.


Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.

Jinesh G, Brohl A Signal Transduct Target Ther. 2022; 7(1):296.

PMID: 35999218 PMC: 9399134. DOI: 10.1038/s41392-022-01132-6.


Pannexin 1 Regulates Skeletal Muscle Regeneration by Promoting Bleb-Based Myoblast Migration and Fusion Through a Novel Lipid Based Signaling Mechanism.

Suarez-Berumen K, Collins-Hooper H, Gromova A, Meech R, Sacco A, Dash P Front Cell Dev Biol. 2021; 9:736813.

PMID: 34676213 PMC: 8523994. DOI: 10.3389/fcell.2021.736813.


References
1.
Maugeri-Sacca M, Vici P, Di Lauro L, Barba M, Amoreo C, Gallo E . Cancer stem cells: are they responsible for treatment failure?. Future Oncol. 2014; 10(13):2033-44. DOI: 10.2217/fon.14.126. View

2.
Kirchhausen T, Macia E, Pelish H . Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol. 2008; 438:77-93. PMC: 2796620. DOI: 10.1016/S0076-6879(07)38006-3. View

3.
Domingues I, Rino J, Demmers J, de Lanerolle P, Santos S . VEGFR2 translocates to the nucleus to regulate its own transcription. PLoS One. 2011; 6(9):e25668. PMC: 3182252. DOI: 10.1371/journal.pone.0025668. View

4.
Lowe M, Rabouille C, Nakamura N, Watson R, JACKMAN M, Jamsa E . Cdc2 kinase directly phosphorylates the cis-Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis. Cell. 1998; 94(6):783-93. DOI: 10.1016/s0092-8674(00)81737-7. View

5.
Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006; 10(6):839-50. DOI: 10.1016/j.devcel.2006.04.002. View